RNST

RENASANT CORP

7 filings tracked

financialsasset managementSMALL ($300M-2B)

Signal Magnitude Chart

bullish

bearish

neutral

Signal Timeline

bullishMay 7

Net income surged 112.5% year-over-year to $88.2 million.

earnings beat

90%

bullishMay 7

Efficiency ratio improved from 65.51% to 55.73%.

margin expansion

70%

bullishMay 7

Expanded share repurchase authorization to $250 million.

buyback

60%

neutralMay 7

Completed $300 million subordinated notes offering in May 2026.

capital raise

50%

bullishMay 7

Net income surged 112.5% year-over-year to $88.2 million.

earnings beat

90%

bullishMay 7

Efficiency ratio improved from 65.51% to 55.73%.

margin expansion

70%

bullishMay 7

Expanded share repurchase authorization to $250 million.

buyback

60%

neutralMay 7

Completed $300 million subordinated notes offering in May 2026.

capital raise

50%

bullishMay 7

Net income surged 112.5% year-over-year to $88.2 million.

earnings beat

90%

bullishMay 7

Efficiency ratio improved from 65.51% to 55.73%.

margin expansion

70%

bullishMay 7

Expanded share repurchase authorization to $250 million.

buyback

60%

neutralMay 7

Completed $300 million subordinated notes offering in May 2026.

capital raise

50%

bullishMay 7

Net income surged 112.5% year-over-year to $88.2 million.

earnings beat

90%

bullishMay 7

Efficiency ratio improved from 65.51% to 55.73%.

margin expansion

70%

bullishMay 7

Expanded share repurchase authorization to $250 million.

buyback

60%

neutralMay 7

Completed $300 million subordinated notes offering in May 2026.

capital raise

50%

bullishMay 7

Net income surged 112.5% year-over-year to $88.2 million.

earnings beat

90%

bullishMay 7

Efficiency ratio improved from 65.51% to 55.73%.

margin expansion

70%

bullishMay 7

Expanded share repurchase authorization to $250 million.

buyback

60%

neutralMay 7

Completed $300 million subordinated notes offering in May 2026.

capital raise

50%

bullishMay 7

Net income surged 112.5% year-over-year to $88.2 million.

earnings beat

90%

bullishMay 7

Efficiency ratio improved from 65.51% to 55.73%.

margin expansion

70%

bullishMay 7

Expanded share repurchase authorization to $250 million.

buyback

60%

neutralMay 7

Completed $300 million subordinated notes offering in May 2026.

capital raise

50%

bullishMay 7

Net income surged 112.5% year-over-year to $88.2 million.

earnings beat

90%

bullishMay 7

Efficiency ratio improved from 65.51% to 55.73%.

margin expansion

70%

bullishMay 7

Expanded share repurchase authorization to $250 million.

buyback

60%

neutralMay 7

Completed $300 million subordinated notes offering in May 2026.

capital raise

50%

Filing History

10-QMay 7, 2026

The Q1 2026 filing presents a classic tug-of-war between aggressive growth and emerging risk. On one hand, Renasant has successfully executed a massive scale-up via M&A, resulting in a dramatic increase in net income and a healthier, asset-sensitive balance sheet. The immediate financial accretion from The First Bancshares merger is undeniable, and the company's ability to grow deposits by over $626 million in a single quarter demonstrates strong market traction. However, the sustainability of this growth is tempered by rising non-interest expenses and a slight uptick in non-performing assets. Investors must weigh the impressive 44.6% jump in diluted EPS against the backdrop of a $1.4 billion goodwill balance and significant unrealized security losses. The overall impact of the filing is a net positive for short-term momentum, but the long-term thesis now hinges on management's ability to stabilize credit quality and fully remediate internal control deficiencies while continuing to integrate acquired assets.